CN101979072A - Chinese medicament for treating chronic liver disease - Google Patents
Chinese medicament for treating chronic liver disease Download PDFInfo
- Publication number
- CN101979072A CN101979072A CN2010105040007A CN201010504000A CN101979072A CN 101979072 A CN101979072 A CN 101979072A CN 2010105040007 A CN2010105040007 A CN 2010105040007A CN 201010504000 A CN201010504000 A CN 201010504000A CN 101979072 A CN101979072 A CN 101979072A
- Authority
- CN
- China
- Prior art keywords
- grams
- rhizoma
- fructus
- chinese
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating chronic liver disease. The Chinese medicament comprises 60 grams of immature bitter orange, 100 grams of oyster, 100 grams of turtle shell, 100 grams of large-headed atractylodes rhizome, 10 grams of bupleurum root, 80 grams of white paeony root, 60 grams of Chinese angelica, 40 grams of common burreed rhizome, 40 grams of zedoary, 60 grams of peach seed, 80 grams of hawthorn fruit, 40 grams of villous amomum fruit, 60 grams of dodder seed and 80 grams of Chinese yam, wherein the accuracy of the dosage of each medicament is +/-10 percent. The Chinese medicament for treating chronic liver disease has effects of regulating qi and blood, eliminating dampness, invigorating spleen and protecting liver, has no relapse after healing, has safe and stable medicinal effect, and has no any side effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of chronic hepatopathy, a kind of specifically Chinese medicine for the treatment of chronic hepatopathy.
Background technology
Chronic hepatopathy belongs to categories such as Chinese medicine is long-pending, hypochondriac pain, jaundice, tympanites.Be by experiencing the epidemic disease poison, the pent-up of feelings will, labor is desired excessively, eating and drinking without temperances etc. injure Liver Channel, undermine the liver network, delay with the passing of time, long-pending forming gradually, be comprehensive and due to the pathogenesis of complexity by " poison, expectorant, heat, the stasis of blood ", multiple pathogenesis interweaves touching through this sick overall process, just give priority in different phase and concrete pattern of syndrome, clinical syndrome deficiency and excess is held concurrently mutually, and is intricate, with the liver function infringement, hepatic fibrosis is main pathological change; Deficiency in origin and excess in superficiality, stagnant heat expectorant poison retardance liver network be its pathogenic characteristic, yet unsatisfactory thoroughly at the therapeutic effect of the medicine of this chronic hepatopathy, some is understood cause toxic and side effects to liver, stomach, kidney, and sufferer self easily develops immunity to drugs.
Summary of the invention
For there are some unfavorable problems in the therapeutic process that solves chronic hepatopathy, the invention provides a kind of Chinese medicine for the treatment of chronic hepatopathy, the Chinese medicine regulating QI treating blood disorders of this kind treatment chronic hepatopathy, dehumidifying spleen invigorating, nourishing the liver protect the liver, and cure the back and do not have repeatedly, the drug effect safety and stability, without any side effects.
Concrete proportioning of the present invention is: Fructus Aurantii Immaturus 60 gram, Concha Ostreae 100 grams, Carapax Trionycis 100 grams, the Rhizoma Atractylodis Macrocephalae 100 grams, Radix Bupleuri 10 grams, the Radix Paeoniae Alba 80 grams, Radix Angelicae Sinensis 60 grams, rhizoma sparganic 40 grams, Rhizoma Curcumae 40 grams, Semen Persicae 60 grams, Fructus Crataegi 80 grams, Fructus Amomi 40 grams, Semen Cuscutae 60 grams, Rhizoma Dioscoreae 80 grams, the degree of accuracy of the dose of this Chinese medicine be each medicine ± 10%.
Pharmacology of the present invention is: Fructus Aurantii Immaturus: let out excess of the stomach, convince hard knot by patient analysis; Radix Angelicae Sinensis: fill blood; Fructus Amomi: the removing dampness appetizing, warming spleen and stopping diarrha, regulating QI is regulated the flow of vital energy; Concha Ostreae: convergence, calmness, detoxifcation, analgesia; The Rhizoma Atractylodis Macrocephalae: invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis; Carapax Trionycis: hard under hectic fever due to YIN-deficiency consumptive fever, malaria with splenomegaly, the side of body, lumbago; Radix Bupleuri: evacuate and bring down a fever the yang invigorating soothing liver-QI; The Radix Paeoniae Alba: relatively hold back liver pain relieving, nourishing blood and hemoslasis; Rhizoma sparganic: removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving; Rhizoma Curcumae: removing blood stasis promoting the circulation of QI to relieve pain, long-pending eliminating stagnation; Semen Persicae: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, relieving cough and asthma; Fructus Crataegi: strengthening the spleen and stomach, help digestion long-pending, clots absorbing blood; Fructus Amomi: the removing dampness appetizing, warming spleen and stopping diarrha, it is antiabortive to regulate the flow of vital energy; Semen Cuscutae: the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, solid tire stopping leak; Rhizoma Dioscoreae: invigorating spleen and reinforcing stomach, aid digestion, kidney nourishing and replenishing vital essence, lung benefiting cough-relieving.
Preparing process of the present invention: Fructus Aurantii Immaturus, Concha Ostreae, Carapax Trionycis, the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, the Radix Paeoniae Alba, Radix Angelicae Sinensis, rhizoma sparganic, Rhizoma Curcumae, Semen Persicae, Fructus Crataegi, Fructus Amomi, Semen Cuscutae, Rhizoma Dioscoreae are put into sieve together, dash with clear water sieve, pull oven dry out after, machine is made pill and is got final product.
Administrated method of the present invention is: every day three times, and each 15 grams, three months is a course of treatment.
The invention has the beneficial effects as follows: the Chinese medicine regulating QI treating blood disorders of this kind treatment chronic hepatopathy, dehumidifying spleen invigorating, nourishing the liver protect the liver, and cure the back and do not have repeatedly, the drug effect safety and stability, without any side effects.
Specific embodiment
Through over 5 years, the clinical practice to 100 examples are treated the patient of chronic hepatopathys has obtained curative effect preferably, and total effective rate reaches 95%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select projects such as medical history, the state of an illness, age, sex and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to the clinical manifestation and the pathological characters branch of treatment chronic hepatopathy, sex, age are not limit, stop using before the treatment other various medicines and therapeutic modality.
4. preparing process: Fructus Aurantii Immaturus, Concha Ostreae, Carapax Trionycis, the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, the Radix Paeoniae Alba, Radix Angelicae Sinensis, rhizoma sparganic, Rhizoma Curcumae, Semen Persicae, Fructus Crataegi, Fructus Amomi, Semen Cuscutae, Rhizoma Dioscoreae are put into sieve together, dash with the clear water sieve, pull oven dry out after, machine is made pill and is got final product.
5. administrated method: every day three times, each 15 grams, three months is a course of treatment.
6. efficacy evaluation
1. recovery from illness: transference cure, thoroughly recovery from illness.
2. remarkable: curing does not afterwards have recurrence more than 1 year.
3. effective: the sufferer symptom of various different chronic hepatitis patients significantly reduces.
4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. sex: according to going into the group standard, we treat chronic hepatitis patients 100 examples altogether, male's 60 examples (60%) wherein, women's 40 examples (40%).
2. the course of disease: 6 months~1 year is 35 examples, and 2 years~3 years is 40 examples, is 25 examples more than 3 years.
3. age group: 20~30 years old 35 example, 31~40 years old 25 example, 41~50 years old 25 example, 51~60 years old 10 example, 5 examples more than 60 years old.
4. prepare the dose scheme for first kind: Fructus Aurantii Immaturus 54 restrains, Concha Ostreae 90 restrains, Carapax Trionycis 90 restrains, the Rhizoma Atractylodis Macrocephalae 90 restrains, Radix Bupleuri 9 restrains, the Radix Paeoniae Alba 72 restrains, Radix Angelicae Sinensis 54 restrains, rhizoma sparganic 36 restrains, Rhizoma Curcumae 36 restrains, Semen Persicae 54 restrains, Fructus Crataegi 72 restrains, Fructus Amomi 36 restrains, Semen Cuscutae 54 restrains, Rhizoma Dioscoreae 72 restrains.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
Patients with mild 50 examples | 40 | 7 | 2 | 1 |
Moderate patient's 35 examples | 30 | 2 | 2 | 1 |
Severe patient 15 examples | 11 | 1 | 1 | 2 |
The scheme of second kind of preparation dose: Fructus Aurantii Immaturus 66 grams, Concha Ostreae 110 grams, Carapax Trionycis 110 grams, the Rhizoma Atractylodis Macrocephalae 110 grams, Radix Bupleuri 11 grams, the Radix Paeoniae Alba 88 grams, Radix Angelicae Sinensis 66 grams, rhizoma sparganic 44 grams, Rhizoma Curcumae 44 grams, Semen Persicae 66 grams, Fructus Crataegi 88 grams, Fructus Amomi 44 grams, Semen Cuscutae 66 grams, Rhizoma Dioscoreae 88 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
Patients with mild 45 examples | 35 | 8 | 1 | 1 |
Moderate patient's 40 examples | 35 | 3 | 1 | 1 |
Severe patient 15 examples | 10 | 3 | 1 | 1 |
The scheme of the third preparation dose: Fructus Aurantii Immaturus 60 grams, Concha Ostreae 100 grams, Carapax Trionycis 100 grams, the Rhizoma Atractylodis Macrocephalae 100 grams, Radix Bupleuri 10 grams, the Radix Paeoniae Alba 80 grams, Radix Angelicae Sinensis 60 grams, rhizoma sparganic 40 grams, Rhizoma Curcumae 40 grams, Semen Persicae 60 grams, Fructus Crataegi 80 grams, Fructus Amomi 40 grams, Semen Cuscutae 60 grams, Rhizoma Dioscoreae 80 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
Patients with mild 50 examples | 40 | 8 | 1 | 1 |
Moderate patient's 40 examples | 35 | 3 | 1 | 1 |
Severe patient 10 examples | 7 | 1 | 1 | 1 |
By Chinese medicine Drug therapy chronic hepatopathy of the present invention, received satisfied curative effect.The symptom of this disease is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.
Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, especially Western medicine is for oral administration, and side effect is bigger, and human body is developed immunity to drugs and causes very big toxic and side effects.In the process of taking Chinese medicine medicine of the present invention, must not take Western medicine and use injection, or other treats this sick medicine.
The Chinese medicine regulating QI treating blood disorders of this kind treatment chronic hepatopathy, dehumidifying spleen invigorating, nourishing the liver protect the liver, and cure the back and do not have repeatedly, the drug effect safety and stability, without any side effects, cure rate reaches 95%.
Claims (2)
1. Chinese medicine for the treatment of chronic hepatopathy, it is characterized in that: concrete proportioning of the present invention is Fructus Aurantii Immaturus 60 gram, Concha Ostreae 100 grams, Carapax Trionycis 100 grams, the Rhizoma Atractylodis Macrocephalae 100 grams, Radix Bupleuri 10 grams, the Radix Paeoniae Alba 80 grams, Radix Angelicae Sinensis 60 grams, rhizoma sparganic 40 grams, Rhizoma Curcumae 40 grams, Semen Persicae 60 grams, Fructus Crataegi 80 grams, Fructus Amomi 40 grams, Semen Cuscutae 60 grams, Rhizoma Dioscoreae 80 grams, the degree of accuracy of the dose of this Chinese medicine be each medicine ± 10%.
2. a kind of Chinese medicine for the treatment of chronic hepatopathy according to claim 1, its preparing process feature is: Fructus Aurantii Immaturus, Concha Ostreae, Carapax Trionycis, the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, the Radix Paeoniae Alba, Radix Angelicae Sinensis, rhizoma sparganic, Rhizoma Curcumae, Semen Persicae, Fructus Crataegi, Fructus Amomi, Semen Cuscutae, Rhizoma Dioscoreae are put into sieve together, dash with the clear water sieve, after pulling oven dry out, machine is made pill and is got final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105040007A CN101979072A (en) | 2010-10-08 | 2010-10-08 | Chinese medicament for treating chronic liver disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105040007A CN101979072A (en) | 2010-10-08 | 2010-10-08 | Chinese medicament for treating chronic liver disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101979072A true CN101979072A (en) | 2011-02-23 |
Family
ID=43599628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105040007A Pending CN101979072A (en) | 2010-10-08 | 2010-10-08 | Chinese medicament for treating chronic liver disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101979072A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727633A (en) * | 2012-07-20 | 2012-10-17 | 成都中医药大学 | Pharmaceutical composition for treating chronic hepatitis B and preparation method and application thereof |
CN103230556A (en) * | 2013-05-15 | 2013-08-07 | 周富贵 | Traditional Chinese medicine for treating cirrhosis and liver cancer and preparation method thereof |
-
2010
- 2010-10-08 CN CN2010105040007A patent/CN101979072A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727633A (en) * | 2012-07-20 | 2012-10-17 | 成都中医药大学 | Pharmaceutical composition for treating chronic hepatitis B and preparation method and application thereof |
CN102727633B (en) * | 2012-07-20 | 2014-03-19 | 成都中医药大学 | Pharmaceutical composition for treating chronic hepatitis B and preparation method and application thereof |
CN103230556A (en) * | 2013-05-15 | 2013-08-07 | 周富贵 | Traditional Chinese medicine for treating cirrhosis and liver cancer and preparation method thereof |
CN103230556B (en) * | 2013-05-15 | 2015-09-09 | 周富贵 | A kind of Chinese medicine and preparation method thereof for the treatment of liver cirrhosis, hepatocarcinoma |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
CN101658657B (en) | Drug for treating chronic cholecystitis | |
CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
CN104173856A (en) | Traditional Chinese medicine composition for treating morbid leukorrhea | |
CN101979072A (en) | Chinese medicament for treating chronic liver disease | |
CN104027522A (en) | Traditional Chinese medicament for treating acute appendicitis | |
CN103495103B (en) | Medicament for promoting digestion and strengthening spleen | |
CN103301401B (en) | A kind of medicated wine and preparation method thereof | |
CN102078432A (en) | Medicament for treating skin itch | |
CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
CN105012612A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
CN104258308A (en) | Traditional Chinese medicine preparation for treating cholelithiasis | |
CN104189777A (en) | Traditional Chinese medicine preparation for treating mastitis | |
CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
CN104173913A (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
CN103768368A (en) | Traditional Chinese medicine composition for treating acute epididymitis | |
CN103520419B (en) | Medicine for treating globus hysteriocus and preparation method thereof | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN105920292A (en) | Chinese medicinal composition for treating acute mastitis | |
CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation | |
CN106075268A (en) | A kind of Chinese medicine composition treating scabies | |
CN104147523A (en) | Traditional Chinese medicine preparation for treating cholecystitis | |
CN104324252A (en) | Traditional Chinese medicine preparation for treating sudden dizziness | |
CN104645224A (en) | Traditional Chinese medicine preparation for treating costal chondritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110223 |